mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with leupeptins in 1 studies
| Studies (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Trials (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Recent Studies (post-2010) (mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin) | Studies (leupeptins) | Trials (leupeptins) | Recent Studies (post-2010) (leupeptins) |
|---|---|---|---|---|---|
| 69 | 0 | 42 | 3,891 | 4 | 1,106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, L; Dai, J; Guan, Y; Li, W; Wang, X; Zhang, Z | 1 |
1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and leupeptins
| Article | Year |
|---|---|
Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS-NF-kappaB pathway.
Topics: Animals; Apolipoproteins E; B-Lymphocytes; Cell Line; DNA-Binding Proteins; Dose-Response Relationship, Drug; Homocysteine; Humans; Hydrocarbons, Fluorinated; Hyperhomocysteinemia; Immunoglobulin G; Leupeptins; Lipopolysaccharides; Liver X Receptors; Luciferases; Metalloporphyrins; Mice; Mice, Knockout; NF-kappa B; Orphan Nuclear Receptors; Reactive Oxygen Species; Receptors, Cytoplasmic and Nuclear; Recombinant Fusion Proteins; Signal Transduction; Spleen; Sulfonamides; Time Factors; Transfection | 2007 |